Hero Image
Ocular Gene Therapy Laboratory

About the Ocular Gene Therapy Laboratory (OGTL)

Designing The Next Generation Of Gene Therapy Treatments

Founded in 2016 by Daniel M. Lipinski, DPhil, the Ocular Gene Therapy Laboratory (OGTL) aims to develop broadly applicable gene-based therapeutics to prevent human blindness arising from neurodegenerative or vascular diseases affecting the retina. Consisting of faculty, students and staff from a diverse range of academic backgrounds, the OGTL laboratory takes a highly multidisciplinary and collaborative approach toward research, working with basic science and clinical investigators worldwide to identify novel therapies for currently untreatable conditions that result in vision loss in humans.   Learn More
OGTL Team Photo 2022_Intro Component New v2